{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:24Z","timestamp":1791475104823,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20CIII\/00040"],"award-info":[{"award-number":["PI20CIII\/00040"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Advanced Therapy Network","award":["RD21\/0017\/0005"],"award-info":[{"award-number":["RD21\/0017\/0005"]}]},{"name":"European Union \u2013 NextGenerationEU"},{"DOI":"10.13039\/501100008545","name":"Asociaci\u00f3n Pablo Ugarte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008545","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Oncohematolog\u00eda Infantil"},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RED2022-134221-T (AdenoNet)"],"award-info":[{"award-number":["RED2022-134221-T (AdenoNet)"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["PID2022-137510OB-I00 and CPP2022-009535"],"award-info":[{"award-number":["PID2022-137510OB-I00 and CPP2022-009535"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00768-2","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:16:58Z","timestamp":1775132218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Alvaro","family":"Morales-Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Franco-Luz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garcia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Africa","family":"Gonz\u00e1lez-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"4","key":"768_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ymthe.2020.01.019","volume":"28","author":"D Ruano","year":"2020","unstructured":"Ruano D, Lopez-Martin JA, Moreno L, Lassaletta A, Bautista F, Andion M, et al. First-in-human, first-in-child trial of autologous MSCs carrying the oncolytic virus Icovir-5 in patients with advanced tumors. Mol Ther. 2020;28(4):1033\u201342.","journal-title":"Mol Ther"},{"issue":"7","key":"768_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/cgt.2010.4","volume":"17","author":"J Garcia-Castro","year":"2010","unstructured":"Garcia-Castro J, Alemany R, Cascallo M, Martinez-Quintanilla J, Arriero MM, Lassaletta A, et al. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther. 2010;17(7):476\u201383.","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"768_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2015.11.036","volume":"371","author":"GJ Melen","year":"2016","unstructured":"Melen GJ, Franco-Luzon L, Ruano D, Gonzalez-Murillo A, Alfranca A, Casco F, et al. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells. Cancer Lett. 2016;371(2):161\u201370.","journal-title":"Cancer Lett"},{"issue":"16","key":"768_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1089\/ars.2021.0167","volume":"35","author":"A Sharma","year":"2021","unstructured":"Sharma A, Kontodimas K, Bosmann M. The MAVS immune recognition pathway in viral infection and sepsis. Antioxid Redox Signal. 2021;35(16):1376\u201392.","journal-title":"Antioxid Redox Signal"},{"issue":"1-2","key":"768_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41417-020-0184-9","volume":"28","author":"MA Rodriguez-Milla","year":"2021","unstructured":"Rodriguez-Milla MA, Morales-Molina A, Perise-Barrios AJ, Cejalvo T, Garcia-Castro J. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses. Cancer Gene Ther. 2021;28(1\u20132):64\u201373.","journal-title":"Cancer Gene Ther"},{"issue":"17","key":"768_CR6","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1158\/0008-5472.CAN-17-3754","volume":"78","author":"T Cejalvo","year":"2018","unstructured":"Cejalvo T, Perise-Barrios AJ, Del Portillo I, Laborda E, Rodriguez-Milla MA, Cubillo I, et al. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy. Cancer Res. 2018;78(17):4891\u2013901.","journal-title":"Cancer Res"},{"issue":"28","key":"768_CR7","doi-asserted-by":"publisher","first-page":"45415","DOI":"10.18632\/oncotarget.17557","volume":"8","author":"E Rincon","year":"2017","unstructured":"Rincon E, Cejalvo T, Kanojia D, Alfranca A, Rodriguez-Milla MA, Gil Hoyos RA, et al. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model. Oncotarget. 2017;8(28):45415\u201331.","journal-title":"Oncotarget"},{"issue":"10","key":"768_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00262-018-2220-2","volume":"67","author":"A Morales-Molina","year":"2018","unstructured":"Morales-Molina A, Gambera S, Cejalvo T, Moreno R, Rodriguez-Milla MA, Perise-Barrios AJ, et al. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice. Cancer Immunol Immunother. 2018;67(10):1589\u2013602.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"768_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051104","volume":"12","author":"L Franco-Luzon","year":"2020","unstructured":"Franco-Luzon L, Garcia-Mulero S, Sanz-Pamplona R, Melen G, Ruano D, Lassaletta A, et al. Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in a neuroblastoma outlier patient. Cancers (Basel). 2020;12(5):1104.","journal-title":"Cancers (Basel)"},{"key":"768_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01030","volume":"11","author":"Z Ren","year":"2020","unstructured":"Ren Z, Ding T, Zuo Z, Xu Z, Deng J, Wei Z. Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front Immunol. 2020;11:1030.","journal-title":"Front Immunol"},{"issue":"5","key":"768_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122(5):669\u201382.","journal-title":"Cell"},{"issue":"5","key":"768_CR12","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1073\/pnas.77.5.2424","volume":"77","author":"G Akusjarvi","year":"1980","unstructured":"Akusjarvi G, Mathews MB, Andersson P, Vennstrom B, Pettersson U. Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci USA. 1980;77(5):2424\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"768_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.01085-19","volume":"93","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Karijolich J. Know thyself: RIG-I-Like Receptor sensing of DNA virus infection. J Virol. 2019;93(23):10\u20131128.","journal-title":"J Virol"},{"issue":"3","key":"768_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1158\/2767-9764.CRC-22-0365","volume":"3","author":"A Morales-Molina","year":"2023","unstructured":"Morales-Molina A, Rodriguez-Milla MA, Gambera S, Cejalvo T, de Andres B, Gaspar ML, et al. Toll-like Receptor signaling-deficient cells enhance antitumor activity of cell-based immunotherapy by increasing tumor homing. Cancer Res Commun. 2023;3(3):347\u201360.","journal-title":"Cancer Res Commun"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00768-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:17:00Z","timestamp":1775132220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00768-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00768-2","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved human participants in a compassionate use program, which in Spain are individually authorized by the Spanish Agency for Medicines and Medical Devices (AEMPS) and by the ethics committee of the hospital, upon obtaining written informed consent from each patient. Compassionate use authorizations are granted by the AEMPS when a clinical trial of the same investigational product is ongoing, as was the case here. The referenced clinical trial (EudraCT 2008-000364-16; NCT01844661) was approved by the Institutional Review Board of Hospital Universitario Ni\u00f1o Jes\u00fas and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All animal protocols were approved by the pertinent ethical committees and carried out in accordance with the guidelines of the European directives and Spanish laws.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}